Rossari Biotech Limited — Results, 28-01-2025: Integrated Filing- Financial

Rossari Biotech Limited has released its financial results for the quarter and nine months ending December 31, 2024. The company's revenue from operations rose to ₹3,682.78 crore, up from ₹2,987.52 crore in the same quarter last year, while total income reached ₹3,692.84 crore. For the nine-month period, income increased to ₹10,083.21 crore compared to ₹8,945.35 crore previously. The profit after tax for the quarter was ₹306.31 crore, showing robust growth. The establishment of a wholly owned subsidiary in Saudi Arabia and the issuance of new equity shares indicate strategic expansion. Investors may view this news positively due to growth in revenue and net income, signaling strong operational performance.